JUN 29, 2020 3:14 AM PDT

Childhood Vaccine May Help Prevent Severe COVID-19 Cases

WRITTEN BY: Carmen Leitch

Vaccines that contain live attenuated viruses may be giving people some protection from serious cases of COVID-19 that involve inflammatory responses that go into overdrive, like cytokine storms and sepsis. One such vaccine is MMR (measles, mumps, and rubella). New research has suggested that these vaccines can stimulate immune cells in a way that primes white blood cells to react more effectively when they encounter other unrelated infections. The findings have been reported in mBio.

Colorized scanning electron micrograph of an apoptotic cell (blue) heavily infected with SARS-COV-2 virus particles (yellow), isolated from a patient sample. Image captured at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. / Credit: NIAID

The protection that's provided by the vaccine is not directed specifically at a virus like SARS-CoV-2, but acts in a more general way to mitigate an uncontrolled inflammatory response that can be triggered during the infection. Research involving experimental models suggested that long-lived cells called myeloid-derived suppressor cells (MDSCs) may be involved in this process.

The scientists involved in the study note that while adults may have gotten the MMR vaccine as children, it may not still be providing this protection and a booster is advisable to reduce the risk posed by the pandemic.

"The use of childhood live attenuated vaccines such as MMR given to adults to induce bystander cells that can dampen or reduce severe complications associated with COVID-19 infection is a low risk - high reward preventive measure during a critical period of the pandemic," said study author Paul Fidel, Jr., Ph.D., Professor and Director of the Center of Excellence in Oral and Craniofacial Biology and Associate Dean for Research at LSU Health New Orleans School of Dentistry.

"These bystander cells are long-lived but not life-long. Anyone who had an MMR vaccination as a child, while likely to still have immune antibodies directed against measles, mumps, or rubella, will not likely still have the immune cells directed against sepsis. So, it could be important to get the MMR vaccination as an adult to protect better against COVID-related sepsis."

Researchers in several locations in Europe are now trying to determine if the live attenuated tuberculosis vaccine can provide this kind of immune primer.

Fidel and study co-author Mairi Noverr, Ph.D., Professor of Microbiology & Immunology at Tulane University School of Medicine in New Orleans suggested that the activation of MDSCs are part of the immune response's training and this may be reducing the severe lung inflammation that's been associated with COVID-19.

"While we initiate the clinical trials and animal model studies to test the hypothesis that the MMR vaccine given to adults induces the bystander cells that we propose can inhibit the severe lung inflammation/sepsis associated with COVID-19 infection, we suggest adults working in high-risk settings who are not immunocompromised, pregnant or allergic to vaccinations, get an MMR vaccine/booster," Fidel noted.

"If we're correct, an MMR-vaccinated person may suffer less if infected with COVID-19. If we're wrong, the person has better immunity to measles, mumps, and rubella. A sort of no harm no foul action."

Sources: AAAS/Eurekalert! via Louisiana State University Health Sciences Center, mBio

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
APR 13, 2021
Immunology
Food-borne Fungus Impedes Gut Healing
APR 13, 2021
Food-borne Fungus Impedes Gut Healing
In a recent study, researchers discovered that a fungus present in cheese, processed meats, beer, and other fermented fo ...
MAY 04, 2021
Cell & Molecular Biology
A Potential Weakness in SARS-CoV-2 is Caught on Video
MAY 04, 2021
A Potential Weakness in SARS-CoV-2 is Caught on Video
You can see the spike protein of the virus in action in this video.
MAY 11, 2021
Clinical & Molecular DX
Every Minute Counts: Opportunities for Faster Blood Culture Results
MAY 11, 2021
Every Minute Counts: Opportunities for Faster Blood Culture Results
Sepsis is one of the most significant challenges in critical care, and early diagnosis is a decisive factor in determini ...
MAY 28, 2021
Genetics & Genomics
Some Biofilms Seem to Activate Cancer Genes
MAY 28, 2021
Some Biofilms Seem to Activate Cancer Genes
New research assessed bacterial and fungal biofilms, tenacious microbial communities that are tougher than small groups ...
JUN 01, 2021
Immunology
Nanoparticles Designed to Enhance Seasonal Flu Vaccines
JUN 01, 2021
Nanoparticles Designed to Enhance Seasonal Flu Vaccines
Seasonal flu vaccines only work around 40 to 60 percent of the time, says the U.S. Centers for Disease Control and Preve ...
JUN 04, 2021
Cell & Molecular Biology
Even When They're Outside the Brain, Infections Worsen Alzheimer's
JUN 04, 2021
Even When They're Outside the Brain, Infections Worsen Alzheimer's
It's thought that inflammation is closely connected to cognitive decline, and neuroinflammation plays a role role in the ...
Loading Comments...